Natus Medical reported $73.04M in Gross Profit on Sales for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abiomed ABMD:US $ 218.39M 4.84M
Accuray ARAY:US $ 34.78M 7.84M
Atricure ATRC:US $ 55.6M 0.58M
Boston Scientific BSX:US $ 2059M 85M
Cardiovascular Systems CSII:US $ 41.43M 0.37M
Cooper Companies COO:US $ 518.4M 16.5M
Edwards Lifesciences EW:US $ 1041.9M 21.7M
General Electric GE:US $ 4211M 852M
Globus Medical GMED:US $ 171.38M 16.84M
Inogen INGN:US $ 35.01M 3.58M
Insulet PODD:US $ 209.7M 3.5M
Integra Lifesciences IART:US $ 238.6M 16.25M
Koninklijke Philips PHG:US 1.51B 408M
Masimo MASI:US $ 204.76M 10.13M
Medtronic MDT:US $ 5330M 20M
Mesa Laboratories MLAB:US $ 28.63M 5.49M
Natus Medical BABY:US $ 73.04M 5.4M
Perkinelmer PKI:US $ 679.23M 69.89M
Philips PHIA:NA € 1918M 56M
Surmodics SRDX:US $ 21M 2.49M
Tandem Diabetes Care TNDM:US $ 91.09M 22.64M
Thermo Fisher Scientific TMO:US $ 5464M 210M